Circulating Tumor Cells Prognostic Technologies Market - Global Outlook and Forecast 2021-2027

Code: RW00014574940
Market Monitor Global
Oct-2021
Life Sciences
91 Pages

This report contains market size and forecasts of Circulating Tumor Cells (CTCs) Prognostic Technologies in Global, including the following market information:
Global Circulating Tumor Cells (CTCs) Prognostic Technologies Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Circulating Tumor Cells (CTCs) Prognostic Technologies market was valued at 1493.8 million in 2020 and is projected to reach US$ 2546.1 million by 2027, at a CAGR of 14.3% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Circulating Tumor Cells (CTCs) Prognostic Technologies companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Circulating Tumor Cells (CTCs) Prognostic Technologies Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Circulating Tumor Cells (CTCs) Prognostic Technologies Market Segment Percentages, By Type, 2020 (%)
Tumor Cell Enrichment
Tumor Cell Detection

China Circulating Tumor Cells (CTCs) Prognostic Technologies Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Circulating Tumor Cells (CTCs) Prognostic Technologies Market Segment Percentages, By Application, 2020 (%)
Prostate Cancer
Breast Cancer
Colorectal Cancer
Lung Cancer
Ovarian Cancer
Pancreatic Cancer

Global Circulating Tumor Cells (CTCs) Prognostic Technologies Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Circulating Tumor Cells (CTCs) Prognostic Technologies Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Total Circulating Tumor Cells (CTCs) Prognostic Technologies Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Circulating Tumor Cells (CTCs) Prognostic Technologies Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
AdnaGen
ACDBio
Celula
Epic Sciences
Fluxion Biosciences
Rarecells
Silicon Biosystems
Vitatex

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Circulating Tumor Cells (CTCs) Prognostic Technologies Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Circulating Tumor Cells (CTCs) Prognostic Technologies Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Circulating Tumor Cells (CTCs) Prognostic Technologies Overall Market Size
2.1 Global Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size: 2021 VS 2027
2.2 Global Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Circulating Tumor Cells (CTCs) Prognostic Technologies Players in Global Market
3.2 Top Global Circulating Tumor Cells (CTCs) Prognostic Technologies Companies Ranked by Revenue
3.3 Global Circulating Tumor Cells (CTCs) Prognostic Technologies Revenue by Companies
3.4 Top 3 and Top 5 Circulating Tumor Cells (CTCs) Prognostic Technologies Companies in Global Market, by Revenue in 2020
3.5 Global Companies Circulating Tumor Cells (CTCs) Prognostic Technologies Product Type
3.6 Tier 1, Tier 2 and Tier 3 Circulating Tumor Cells (CTCs) Prognostic Technologies Players in Global Market
3.6.1 List of Global Tier 1 Circulating Tumor Cells (CTCs) Prognostic Technologies Companies
3.6.2 List of Global Tier 2 and Tier 3 Circulating Tumor Cells (CTCs) Prognostic Technologies Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size Markets, 2021 & 2027
4.1.2 Tumor Cell Enrichment
4.1.3 Tumor Cell Detection
4.2 By Type - Global Circulating Tumor Cells (CTCs) Prognostic Technologies Revenue & Forecasts
4.2.1 By Type - Global Circulating Tumor Cells (CTCs) Prognostic Technologies Revenue, 2016-2021
4.2.2 By Type - Global Circulating Tumor Cells (CTCs) Prognostic Technologies Revenue, 2022-2027
4.2.3 By Type - Global Circulating Tumor Cells (CTCs) Prognostic Technologies Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size, 2021 & 2027
5.1.2 Prostate Cancer
5.1.3 Breast Cancer
5.1.4 Colorectal Cancer
5.1.5 Lung Cancer
5.1.6 Ovarian Cancer
5.1.7 Pancreatic Cancer
5.2 By Application - Global Circulating Tumor Cells (CTCs) Prognostic Technologies Revenue & Forecasts
5.2.1 By Application - Global Circulating Tumor Cells (CTCs) Prognostic Technologies Revenue, 2016-2021
5.2.2 By Application - Global Circulating Tumor Cells (CTCs) Prognostic Technologies Revenue, 2022-2027
5.2.3 By Application - Global Circulating Tumor Cells (CTCs) Prognostic Technologies Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size, 2021 & 2027
6.2 By Region - Global Circulating Tumor Cells (CTCs) Prognostic Technologies Revenue & Forecasts
6.2.1 By Region - Global Circulating Tumor Cells (CTCs) Prognostic Technologies Revenue, 2016-2021
6.2.2 By Region - Global Circulating Tumor Cells (CTCs) Prognostic Technologies Revenue, 2022-2027
6.2.3 By Region - Global Circulating Tumor Cells (CTCs) Prognostic Technologies Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Circulating Tumor Cells (CTCs) Prognostic Technologies Revenue, 2016-2027
6.3.2 US Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size, 2016-2027
6.3.3 Canada Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size, 2016-2027
6.3.4 Mexico Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Circulating Tumor Cells (CTCs) Prognostic Technologies Revenue, 2016-2027
6.4.2 Germany Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size, 2016-2027
6.4.3 France Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size, 2016-2027
6.4.4 U.K. Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size, 2016-2027
6.4.5 Italy Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size, 2016-2027
6.4.6 Russia Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size, 2016-2027
6.4.7 Nordic Countries Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size, 2016-2027
6.4.8 Benelux Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Circulating Tumor Cells (CTCs) Prognostic Technologies Revenue, 2016-2027
6.5.2 China Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size, 2016-2027
6.5.3 Japan Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size, 2016-2027
6.5.4 South Korea Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size, 2016-2027
6.5.5 Southeast Asia Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size, 2016-2027
6.5.6 India Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Circulating Tumor Cells (CTCs) Prognostic Technologies Revenue, 2016-2027
6.6.2 Brazil Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size, 2016-2027
6.6.3 Argentina Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Circulating Tumor Cells (CTCs) Prognostic Technologies Revenue, 2016-2027
6.7.2 Turkey Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size, 2016-2027
6.7.3 Israel Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size, 2016-2027
6.7.4 Saudi Arabia Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size, 2016-2027
6.7.5 UAE Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size, 2016-2027
7 Players Profiles
7.1 AdnaGen
7.1.1 AdnaGen Corporate Summary
7.1.2 AdnaGen Business Overview
7.1.3 AdnaGen Circulating Tumor Cells (CTCs) Prognostic Technologies Major Product Offerings
7.1.4 AdnaGen Circulating Tumor Cells (CTCs) Prognostic Technologies Revenue in Global (2016-2021)
7.1.5 AdnaGen Key News
7.2 ACDBio
7.2.1 ACDBio Corporate Summary
7.2.2 ACDBio Business Overview
7.2.3 ACDBio Circulating Tumor Cells (CTCs) Prognostic Technologies Major Product Offerings
7.2.4 ACDBio Circulating Tumor Cells (CTCs) Prognostic Technologies Revenue in Global (2016-2021)
7.2.5 ACDBio Key News
7.3 Celula
7.3.1 Celula Corporate Summary
7.3.2 Celula Business Overview
7.3.3 Celula Circulating Tumor Cells (CTCs) Prognostic Technologies Major Product Offerings
7.3.4 Celula Circulating Tumor Cells (CTCs) Prognostic Technologies Revenue in Global (2016-2021)
7.3.5 Celula Key News
7.4 Epic Sciences
7.4.1 Epic Sciences Corporate Summary
7.4.2 Epic Sciences Business Overview
7.4.3 Epic Sciences Circulating Tumor Cells (CTCs) Prognostic Technologies Major Product Offerings
7.4.4 Epic Sciences Circulating Tumor Cells (CTCs) Prognostic Technologies Revenue in Global (2016-2021)
7.4.5 Epic Sciences Key News
7.5 Fluxion Biosciences
7.5.1 Fluxion Biosciences Corporate Summary
7.5.2 Fluxion Biosciences Business Overview
7.5.3 Fluxion Biosciences Circulating Tumor Cells (CTCs) Prognostic Technologies Major Product Offerings
7.5.4 Fluxion Biosciences Circulating Tumor Cells (CTCs) Prognostic Technologies Revenue in Global (2016-2021)
7.5.5 Fluxion Biosciences Key News
7.6 Rarecells
7.6.1 Rarecells Corporate Summary
7.6.2 Rarecells Business Overview
7.6.3 Rarecells Circulating Tumor Cells (CTCs) Prognostic Technologies Major Product Offerings
7.6.4 Rarecells Circulating Tumor Cells (CTCs) Prognostic Technologies Revenue in Global (2016-2021)
7.6.5 Rarecells Key News
7.7 Silicon Biosystems
7.7.1 Silicon Biosystems Corporate Summary
7.7.2 Silicon Biosystems Business Overview
7.7.3 Silicon Biosystems Circulating Tumor Cells (CTCs) Prognostic Technologies Major Product Offerings
7.4.4 Silicon Biosystems Circulating Tumor Cells (CTCs) Prognostic Technologies Revenue in Global (2016-2021)
7.7.5 Silicon Biosystems Key News
7.8 Vitatex
7.8.1 Vitatex Corporate Summary
7.8.2 Vitatex Business Overview
7.8.3 Vitatex Circulating Tumor Cells (CTCs) Prognostic Technologies Major Product Offerings
7.8.4 Vitatex Circulating Tumor Cells (CTCs) Prognostic Technologies Revenue in Global (2016-2021)
7.8.5 Vitatex Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Circulating Tumor Cells (CTCs) Prognostic Technologies Market Opportunities & Trends in Global Market
Table 2. Circulating Tumor Cells (CTCs) Prognostic Technologies Market Drivers in Global Market
Table 3. Circulating Tumor Cells (CTCs) Prognostic Technologies Market Restraints in Global Market
Table 4. Key Players of Circulating Tumor Cells (CTCs) Prognostic Technologies in Global Market
Table 5. Top Circulating Tumor Cells (CTCs) Prognostic Technologies Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Circulating Tumor Cells (CTCs) Prognostic Technologies Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Circulating Tumor Cells (CTCs) Prognostic Technologies Revenue Share by Companies, 2016-2021
Table 8. Global Companies Circulating Tumor Cells (CTCs) Prognostic Technologies Product Type
Table 9. List of Global Tier 1 Circulating Tumor Cells (CTCs) Prognostic Technologies Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Circulating Tumor Cells (CTCs) Prognostic Technologies Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE